Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg recall — FDA D-0004-2023
Superpotent Drug: Out of specification for assay at the 12-month timepoint.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Superpotent Drug: Out of specification for assay at the 12-month timepoint.
Volkswagen Group of America, Inc. (Volkswagen) is recalling certain 2021 Audi A8, RS7, RS6 Avant, RS5 Sportback, RS5 Coupe, Q8, Q7, Q5 Sportback, S4 Sedan, Q5, A7, A6, A6 Allroad, A5…
Ford Motor Company (Ford) is recalling certain 2022 Maverick vehicles. Under certain circumstances, the Antilock Brake System (ABS) module may cause the brake lights to illuminate without…
General Motors, LLC (GM) is recalling certain 2022-2023 Chevrolet Equinox and 2022 GMC Terrain vehicles. The driver's seat may have a stripped or loose bolt at the seat frame height-adjust…
Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,
Volkswagen Group of America, Inc. (Volkswagen) is recalling certain 2023 model year Atlas FL and Atlas Cross Sport vehicles. Certain brake lines may leak at the threaded connections.
General Motors, LLC (GM) is recalling certain 2020-2021 Cadillac XT5, XT6, and GMC Acadia vehicles equipped with the optional Surround Vision feature. The rearview camera coaxial cable…
General Motors, LLC (GM) is recalling certain 2023 Cadillac XT5, XT6, and GMC Acadia vehicles. The certification label located on the driver's side B-pillar contains tire size information…
Subaru of America, Inc. (Subaru) is recalling certain 2022 Impreza and Outback vehicles. The incorrect paint clearcoat may have been applied, which can cause the windshield to be…
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Chemical contamination: presence of benzene
Microbial contamination of non-sterile products.
CGMP Deviations: FDA analysis found product to contain acetaldehyde impurity and the Sum of All Impurities, above specification limits.
CGMP Deviations
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
Microbial contamination of non-sterile products.
CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.
Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.
Microbial contamination of non-sterile products.
CGMP Deviations;
CGMP Deviations
Browse recent months with enough recall history for useful comparison.